Preferred Solution Provider

At L&R, people and their healthcare have always been our main focus. The tagline People.Health.Care. draws attention to three independent areas that together form the essence of L&R’s vision and values: People are our top priority and therefore at the heart of everything we do. Their health is both L&R’s area of expertise and sphere of activity. Care embodies the brand values of trust, customer and service focus, as well as the idea of L&R as a reliable partner. As a trusted solution provider, we are well positioned to help people worldwide with this three-pronged approach. 

Take charge of your wound care challenges with our Advanced Wound Care system.

⇒ Step 1:

Wound Bed Preparation

More than 90% of chronic wounds contain bacteria and fungi bioburden.¹ Debrisoft® monofilament devices provide a therapeutic way to penetrate, disrupt, and detach biofilm, slough, keratosis, and non-viable debris in both acute and chronic wounds. In addition, Debrisoft protects granulation tissue formation in a virtually painless procedure.

Explore real-world effectiveness studies illustrating the clinical efficacy of Debrisoft.

Shop Debrisoft

⇒ Step 2:

Wound Treatment

For over 170 years, L&R has been working with clinicians to gain insights in manufacturing products that provide a comprehensive range of advanced wound dressings to help meet a wide range of wound care needs.

With L&R’s portfolio of advanced wound care products, you will find the best solutions for optimal advanced wound care management. Find the right product solutions below.

Shop Wound Treatment

Shop Collagens

⇒ Step 3:

Compression Therapy

The breadth and width of our compression therapy product line contains specialized options for specific treatment objectives. As an international leader, our compression therapy products provide the results professionals look for when treating their patients.

Shop Compression Therapy

1. Attinger C, Wolcott R. Clinically Addressing Biofilm in Chronic Wounds. Adv Wound Care. 2012;1(3):127‐132. doi:10.1089/wound.2011.0333

SHARE YOUR CART